Methamphetamine and HIV-1 gp120 Effects on Lipopolysaccharide Stimulated Matrix Metalloproteinase-9 Production by Human Monocyte-Derived Macrophages

REFERENCES

• Ancuta, P., Kamat, A., Kunstman, K.J., Kim, E.Y., Autissier, P., Wurcel, A., Zaman, T., Stone, D., Mefford, M., Morgello, S., Singer, E.J., Wolinsky, S.M., Gabuzda, D.(2008). Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS ONE 3(6): e2516. doi:10.1371/journal.pone.0002516.
   Google Scholar
• Annunziata, P. (2003). Blood-brain barrier changes during invasion of the central nervous system by HIV-1. Old and new insights into the mechanism. J. Neurol. 250:901–906.
   PubMed Web of Science ®Google Scholar
• Baroncelli, S., Galluzzo, C.M., Pirillo, M.F., Mancini, M.G., Weimer, L.E., Andreotti, M., Amici, R., Vella, S., Giuliano, M., Palmisano, L. (2009). Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with <50copies/ml HIV-1 RNA. J. Clin. Virol. 46(4):367–370.
   PubMed Web of Science ®Google Scholar
• Brenchley, J.M., Price, D.A., Schacker, T.W., Asher, T.E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., Blazar, B.R., Rodriguez, B., Teixeira-Johnson, L, Landay, A.., Martin, J.N., Hecht, F.M., Picker, L.J., Lederman, M.M., Deeks, S.G., Douek, D.C. (2006). Microbial translocation is a cause of systemic immune activation in chonic HIV infection. Nat. Med. 12(12):1365–1371.
   PubMed Web of Science ®Google Scholar
• Brenchley, J.M., Douek, D.C. (2008). HIV infection and the gastrointestinal immune system. Mucosal Immunol. 1(1):23–30.
   PubMed Web of Science ®Google Scholar
• Buckner, C., Luers, A., Calderon, T., Eugenin, E., Berman, J. (2006). Neuroimmunity and the blood–brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on NeuroAIDS. J. NeuroImmune Pharmacol. 1:160–181.
   PubMed Web of Science ®Google Scholar
• Cheung, R., Ravyn, V., Wang, L., Ptasznik, A., Collman, R.G. (2008). Signaling mechanism of HIV-1 gp120 and virion-induced IL-1beta release in primary human macrophages. J. Immunol. 180:6675–6684.
   Google Scholar
• Ciccone, E.J., Read, S.W., Mannon, P.J., Yao, M.D., Hodge, J.N., Dewar, R., Chairez, C.L., Proschan, M.A., Kovacs, J.A., Sereti, I. (2010). Cycling of gut mucosal CD4+ T cells decreases after prolonged anti-retroviral therapy and is associated with plasma LPS levels. Mucosal Immunol. 3(2):172–181.
   PubMed Web of Science ®Google Scholar
• Conant, K., McArthur, J.C., Griffin, D.E., Sjulson, L., Wahl, L.M., Irani, D.N. (1999). Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann. Neurol. 46(3):391–398.
   Google Scholar
• Conant, K., St Hillaire, C., Anderson, C., Galey, D., Wang, J., Nath, A. (2004). Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases. J. Neurovirol. 10(1):21–28.
   PubMed Web of Science ®Google Scholar
• Dallasta, L.M., Pisarov, L.A., Esplen, J.E., Werley, J.V., Moses, A.V., Nelson, J.A., Achim, C.L. (1999). Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 155(6):1915–1927.
   Web of Science ®Google Scholar
• Davis, L.E., Hjelle, B.L., Miller, V.E., Palmer, D.L., Llewellyn, A.L., Merlin, T.L., Young, S.A, Mills, R.G., Wachsman, W., Wiley, C.A. (1992). Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42:1736–1739.
   PubMed Web of Science ®Google Scholar
• Dhawan, S., Toro, L.A., Jones, B.E., Meltzer, M.S. (1992). Interaction between HIV-infected monocytes and the extracellular matrix: HIV-infected monocytes secrete neutral metalloproteases that degrade basement membrane protein matrices. J. Leukoc. Biol. 52:244–248.
   PubMedGoogle Scholar
• Dzwonek, J., Rylski, M., Kaczmarek, L. (2004). Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Lett. 567(1):129–135.
   Google Scholar
• Eugenin, E.A., Osiecki, K., Lopez, L., Goldstein, H., Calderon, T.M., Berman, J.W. (2006). CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: A potential mechanism of HIV-CNS invasion and neuroAIDS. J. Neurosci. 26:1098–1106.
   PubMed Web of Science ®Google Scholar
• Ferris, M.J., Mactutus, C.F., Booze, R.M. (2008). Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain:current status of dopamine system vulnerability in NeuroAIDS. Neurosci. Biobehav. Rev. 32:883–909.
   Google Scholar
• Friedman, H., Newton, C., Klein, T.W. (2003). Microbial infections, immunomodulation, and drugs of abuse. Clin. Microbiol. Rev. 16: 209–219.
   PubMed Web of Science ®Google Scholar
• Gaskill, P.J., Calderon, T.M., Luers, A.J., Eugenin, E.A., Javitch, J.A., Berman, J.W. (2009). Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse. Am. J. Pathol. 175(3):1148–1159.
   Google Scholar
• Gendelman, H.E., Persidsky, Y., Ghorpade, A., Limoges, J., Stins, M., Fiala, M., Morrisett, R. (1997). The neuropathogenesis of the AIDS dementia complex. AIDS 11 Suppl A:S35–45.
   Google Scholar
• Ghorpade, A., Persidskaia, R., Suryadevara, R., Che, M., Liu, X.J., Persidsky, Y., Gendelman, H.E. (2001). Mononuclear phagocyte differentiation, activation, and viral infection regulate matrix metalloproteinase expression: implications for human immunodeficiency virus type 1-associated dementia. J. Virol. 75(14):6572–6583.
   PubMed Web of Science ®Google Scholar
• Gras, G., Kaul, M. (2010). Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection. Retrovirology 7:30.
   PubMed Web of Science ®Google Scholar
• Hamamoto, D.T., Rhodus, N.L. (2009). Methamphetamine abuse and dentistry. Oral Dis. 15(1):27–37.
   Google Scholar
• Herbein, G., Varin, A. (2010). The macrophage in HIV-1 infection: from activation to deactivation? Retrovirology 7:33.
   PubMed Web of Science ®Google Scholar
• Jiang, W., Lederman, M.M., Hunt, P., Sieg, S.F., Haley, K., Rodriguez, B., Landay, A., Martin, J., Sinclair, E., Asher, A.I., Deeks. S.G., Douek, D.C., Brenchley, J.M. (2009). Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restorationin persons with antiretroviral-treated HIV infection. J. Infect. Dis. 199(8):1177–1185.
   PubMed Web of Science ®Google Scholar
• Ju, S.M., Song, H.Y., Lee, J.A., Lee, S.J., Choi, S.Y., Park, J. (2009). Extracellular HIV-1 Tat up-regulates expression of matrix metalloproteinase-9 via a MAPK-NF-kappaB dependent pathway in human astrocytes. Exp. Mol. Med. 41(2):86–93.
   PubMed Web of Science ®Google Scholar
• Kaczmarek, L., Lapinska-Dzwonek, J., Szymczak, S. (2002). Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections? EMBO J. 21(24):6643–6648.
   Google Scholar
• Kaul, M., Lipton, S.A.(1999). Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc. Natl. Acad. Sci. USA 96:8212–8216.
   PubMed Web of Science ®Google Scholar
• Kaul, M., Ma, Q., Medders, K.E., Desai, M.K., Lipton, S.A. (2007). HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection. Cell Death Differ. 14:296–305.
   PubMed Web of Science ®Google Scholar
• Kumar, A., Dhawan, S., Mukhopadhyay, A., Aggarwal, B.B. (1999). Human immunodeficiency virus-1-tat induces matrix metalloproteinase-9 in monocytes though protein tyrosine phosphatase-mediated activation of nuclear transcription factor NF-kappaB. FEBS Lett. 462(1–2):140–144.
   Google Scholar
• Lai, W.C., Zhou, M., Shankavaram, U., Peng, G., Wahl, L.M. (2003). Differential regulation of lipopolysaccharide-induced monocyte matrix metalloproteinase (MMP)-1 and MMP-9 by p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J. Immunol. 170(12):6244–6249.
   PubMed Web of Science ®Google Scholar
• Leber, T.M., Balkwill, F.R. (1998). Regulation of monocyte MMP-9 production by TNF-alpha and a tumour-derived soluble factor (MMPSF). Br. J. Cancer 78(6):724–732.
   Google Scholar
• Leber, T.M, Balkwill, F.R. (1997). Zymography: A single-step staining method for quantitation of proteolytic activity on substrate gels. Anal. Biochem. 249(1):24–28.
   Google Scholar
• Lee, W.J., Shin, C.Y., Yoo, B.K., Ryu, J.R., Choi, E.Y., Cheong, J.H., Ryu, J.H., Ko, K.H. (2003). Induction of matrix metalloproteinase-9 (MMP-9) in lipopolysaccharide-stimulated primary astrocytes is mediated by extracellular signal-regulated protein kinase 1/2 (Erk1/2). Glia 41(1):15–24.
   PubMed Web of Science ®Google Scholar
• Liuzzi, G.M., Mastroianni, C.M., Santacroce, M.P., Fanelli, M., D’Agostino, C., Vullo, V., Riccio, P. (2000). Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases. J. Neurovirol. 6(2):156–163.
   PubMed Web of Science ®Google Scholar
• Louboutin, J.P., Agrawal, L., Reyes, B.A., Van Bockstaele, E.J., Strayer, D.S. (2010). HIV-1 gp120-induced injury to the blood-brain barrier: role of metalloproteinases 2 and 9 and relationship to oxidative stress. J. Neuropathol. Exp. Neurol. 69(8):801–816.
   PubMed Web of Science ®Google Scholar
• Lu, Y., Wahl, L.M. (2005). Production of matrix metalloproteinase-9 by activated human monocytes involves a phosphatidylinositol-3 kinase/Akt/IKKalpha/NF-kappaB pathway. J. Leukoc. Biol. 78(1):259–265.
   Google Scholar
• Mahajan, S.D., Aalinkeel, R., Reynolds, J.L., Nair, B.B., Fernandez, S.F., Schwartz, S.A, Nair, M.P. (2005). Morphine exacerbates HIV-1 viral protein gp120 induced modulation of chemokine gene expression in U373 astrocytoma cells. Curr. HIV Res. 3(3):277–288.
   Google Scholar
• Mannello, F., Gazzanelli, G. (2001). Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implications. Apoptosis 6(6):479–482.
   Google Scholar
• Medders, K.E., Sejbuk, N.E., Maung, R., Desai, M.K., Kaul, M. (2010). Activation of p38 MAPK is required in monocytic and neuronal cells for HIV glycoprotein 120-induced neurotoxicity. J. Immunol. 185(8):4883–4895.
   Web of Science ®Google Scholar
• Missé, D., Esteve, P.O., Renneboog, B., Vidal, M., Cerutti, M., St Pierre, Y., Yssel, H., Parmentier, M., Veas, F. (2001). HIV-1 glycoprotein 120 induces the MMP-9 cytopathogenic factor production that is abolished by inhibition of the p38 mitogen-activated protein kinase signaling pathway. Blood 98(3):541–547.
   Google Scholar
• Mizoguchi, H., Yamada, K., Niwa, M., Mouri, A., Mizuno, T., Noda, Y., Nitta, A., Itohara, S., Banno, Y., Nabeshima, T. (2007a). Reduction of methamphetamine-induced sensitization and reward in matrix metalloproteinase-2 and -9-deficient mice. J. Neurochem. 100(6):1579–1588.
   PubMed Web of Science ®Google Scholar
• Mizoguchi, H., Yamada, K., Mouri, A., Niwa, M., Mizuno, T., Noda, Y., Nitta, A., Itohara, S., Banno, Y., Nabeshima, T. (2007b). Role of matrix metalloproteinase and tissue inhibitor of MMP in methamphetamine-induced behavioral sensitization and reward: implications for dopamine receptor down-regulation and dopamine release. J. Neurochem. 102(5):1548–1560.
   Google Scholar
• Mun-Bryce, S., Rosenberg, G.A. (1998). Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. Am. J. Physiol. 274(5 Pt 2):R1203–1211.
   Google Scholar
• Nath, A., Maragos, W.F., Avison, M.J., Schmitt, F.A., Berger, J.R. (2001). Acceleration of HIV dementia with methamphetamine and cocaine. J. Neurovirol. 7(1):66–71.
   PubMed Web of Science ®Google Scholar
• Perfettini, J.L., Castedo, M., Nardacci, R., Ciccosanti, F., Boya, P., Roumier, T., Larochette, N., Piacentini, M., Kroemer, G. (2005). Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope. J. Exp. Med. 201(2):279–289.
   PubMed Web of Science ®Google Scholar
• Power, C., Kong, P.A., Crawford, T.O., Wesselingh, S., Glass, J.D., McArthur, J.C., Trapp, B.D. (1993). Cerebral white matter changes in acquired immunodeficiency syndrome dementia: Alterations of the blood-brain barrier. Ann. Neurol. 34(3):339–350.
   PubMedGoogle Scholar
• Rhee, J.W., Lee, K.W., Kim, D., Lee, Y., Jeon, O.H., Kwon, H.J., Kim, D.S. (2007). NF-kappaB-dependent regulation of matrix metalloproteinase-9 gene expression by lipopolysaccharide in a macrophage cell line RAW 264.7. J. Biochem. Mol. Biol. 40(1):88–94.
   Google Scholar
• Rhodes, R.H. (1991). Evidence of serum-protein leakage across the blood-brain barrier in the acquired immunodeficiency syndrome. J. Neuropathol. Exp. Neurol. 50(2):171–183.
   Google Scholar
• Serra, R., Al-Saidi, A.G., Angelov, N., Nares, S. (2010). Suppression of LPS-induced matrix-metalloproteinase responses in macrophages exposed to phenytoin and its metabolite, 5-(p-hydroxyphenyl-), 5-phenylhydantoin. J. Inflamm. (Lond). 7:48.
   Google Scholar
• Shively, L., Chang, L., LeBon, J.M., Liu, Q., Riggs, A.D., Singer-Sam, J. (2003). Real-time PCR assay for quantitative mismatch detection. BioTechniques 34:498–502.
   Google Scholar
• Speidl, W.S., Toller, W.G., Kaun, C., Weiss, T.W., Pfaffenberger, S., Kastl, S.P., Furnkranz, A., Maurer, G., Huber, K., Metzler, H., Wojta, J. (2004). Catecholamines potentiate LPS-induced expression of MMP-1 and MMP-9 in human monocytes and in the human monocytic cell line U937: possible implications for peri-operative plaque instability. FASEB J. 18(3):603–605.
   Google Scholar
• Sporer, B., Paul, R., Koedel, U., Grimm, R., Wick, M., Goebel, F.D., Pfister, H.W. (1998). Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus infected patients. J. Infect. Dis. 178:854–857.
   PubMed Web of Science ®Google Scholar
• Tallóczy, Z., Martinez, J., Joset, D., Ray, Y., Gácser, A., Toussi, S., Mizushima, N., Nosanchuk, J.D., Goldstein, H., Loike, J., Sulzer, D., Santambrogio, L. (2008). Methamphetamine inhibits antigen processing, presentation, and phagocytosis. PLoS Pathog. 4(2):e28.
   PubMed Web of Science ®Google Scholar
• Tipton, D.A., Legan, Z.T., Dabbous, M.K. (2010). Methamphetamine cytotoxicity and effect on LPS-stimulated IL-1beta production by human monocytes. Toxicol. In Vitro. 24(3):921–927.
   Google Scholar
• Van den Steen, P.E., Dubois, B., Nelissen, I., Rudd, P.M., Dwek, R.A., Opdenakker, G. (2002). Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 37(6):375–536.
   PubMed Web of Science ®Google Scholar
• Visse, R., Nagase, H. (2003). Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92(8):827–839.
   PubMed Web of Science ®Google Scholar
• Vos, C.M., Gartner, S., Ransohoff, R.M., McArthur, J.C., Wahl, L., Sjulson, L., Hunter, E., Conant, K. (2000). Matrix metalloprotease-9 release from monocytes increases as a function of differentiation: implications for neuroinflammation and neurodegeneration. J. Neuroimmunol. 109(2):221–227.
   Google Scholar
• Webster, N.L., Crowe, S.M. (2006). Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases. J. Leukoc. Biol. 80(5):1052–1066.
   PubMed Web of Science ®Google Scholar
• Westhorpe, C.L., Zhou, J., Webster, N.L., Kalionis, B., Lewin, S.R., Jaworowski, A., Muller, W.A., Crowe, S.M. (2009). Effects of HIV-1 infection in vitro on transendothelial migration by monocytes and monocyte-derived macrophages. J. Leukoc. Biol. 85(6):1027–1035.
   Google Scholar
• Williams, K.C., Hickey, W.F. (2002). Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu. Rev. Neurosci. 25:537–562.
   PubMed Web of Science ®Google Scholar
• Wu, D.T., Woodman, S.E., Weiss, J.M., McManus, C.M., D’Aversa, T.G., Hesselgesser, J. (2000). Major EO, Nath A, Berman JW. Mechanisms of leukocyte trafficking into the CNS. J. Neurovirol. 6(Suppl 1):S82–S85.
   PubMedGoogle Scholar
• Zhen, X., Uryu, K., Wang, H.Y., Friedman, E. (1998). D1 dopamine receptor agonists mediate activation of p38 mitogen-activated protein kinase and c-Jun amino-terminal kinase by a protein kinase A-dependent mechanism in SK-N-MC human neuroblastoma cells. Mol. Pharmacol. 54(3):453–458.
   Google Scholar